The number of collaborations between huge pharma companies and AI vendors for drug discovery went from 4 in 2015 to 27 in 2020 with an increase of 575%, in just 6 years.
Request a short version of this report @ https://www.towardshealthcare.com/personalized-scope/5043
According to the stats published by World Health Organization (WHO), approximately 1.28 million adults (between 30 and 79 years of age) have hypertension. Of these, as little as 42% of adults are diagnosed and treated correctly and the remaining population is unaware of this condition. The majority of this population resides in low to middle-income countries of the world. Despite this substantial number of untreated cases, the rising awareness among doctors and the general population regarding health illnesses associated with hypertension is expected to drive the demand for the required devices.
A recent report provides crucial insights along with application based and forecast information in the Global AI in Life Science Industry. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this Industry. This study also provides a detailed overview of the opportunities along with the current trends observed in the AI in Life Science Industry.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the Industry. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Report Objectives
- To define, describe, and forecast the global AI in Life Science Industry based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the Industry (drivers, opportunities, and industry-specific challenges)
- To strategically analyze microIndustrys1 with respect to individual growth trends, future prospects, and contributions to the total Industry
- To analyze opportunities in the Industry for stakeholders and provide details of the competitive landscape for Industry leaders
- To forecast the size of Industry segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, Industry shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the AI in Life Science Industry
Companies and Manufacturers Covered
The study covers key players operating in the Industry along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global AI in Life Science Industry are included as given below:
Contact US -
Towards Healthcare
Web: https://www.towardshealthcare.com/
You can place an order or ask any questions, please feel free to contact at
Email: sales@towardshealthcare.com
About Us
We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
No comments yet